Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
Author
Cardoso, F.
Lin, C.
Gradishar, W.
Azevedo, S.
Ozguroglu, M.
Bachelot, T.
Royce, M.
Villanueva, C.
Melo Cruz, F.
Hegg, R.
Falkson, C.
Jeong, J.
Srimuninnimit, V.
Arce, C. H.
Ridolfi, A.
Metadata
Show full item recordCollections
- Bildiri [64839]